XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]        
Revenues
Expenses:        
Research and development 107,971 738,936
General and administrative 175,735 30,885 1,596,533 583,911
Total operating expenses 283,706 30,885 2,335,469 583,911
Loss from operations (283,706) (30,885) (2,335,469) (583,911)
Finance income (expense), net (259,866) 75,000 (22,249,708) (240,354)
Net income (loss) from continuing operations available to shareholders of the company (543,572) 44,115 (24,585,177) (824,265)
Loss from discontinued operations (Note 6) available to shareholders of the company (101,768) (591,724)
Net loss from continuing operations attributable to shareholders of the company (543,572) (57,654) (24,585,177) (1,415,989)
Net loss attributable to shareholders of preferred stock   (5,216)   (47,691)
Net loss from continuing operations $ (543,572) $ (52,438) $ (24,585,177) $ (1,368,298)
Basic and diluted net income (loss) per share:        
From continuing operations $ (0.01) $ 0.002 $ (0.44) $ (0.04)
From discontinued operations (0.01) (0.03)
Total basic and diluted net loss per share $ (0.01) $ (0.003) $ (0.44) $ (0.07)
Weighted average shares outstanding - basic and diluted 63,727,843 22,543,008 56,235,127 21,523,127